Result Summary for ARI10019

Result Summary
Protocol ID: ARI10019
Clinical Study ID: ARI10019
Official Title: A Double-Blind, Placebo Controlled, Randomized, Parallel Group Study To Investigate The Changes In The Corrected QT Interval Following Repeat Oral Doses Of GI198745 (dutasteride) In Healthy Male Volunteers.
Phase: Phase 1
Study Indications or Diseases:
  • Urologic Diseases
Generic Name: dutasteride
Trade/Product Name: avodart;avodart
Approved Drug Label: http://www.gsk.com/products/prescription-medicines/index.htm
Results Summary: Click here to download result summary. Click here to download result summary.
Citations: